Pharmafile Logo
Pharmafocus logo
Advanced Search
remdesivir_ulrich_perrey

Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients

June 5, 2020
Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …

News
people

British COVID-19 test-and-trace system will not be fully operational until September, despite it launching last month

June 5, 2020
Medical Communications COVID-19, NHS, coronavirus

The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …

News
black_market

The Lancet retracts paper that highlighted the dangers of taking hydroxychloroquine

June 5, 2020
Medical Communications COVID-19, Lancet, hydroxychloroquine

The Lancet has retracted a paper that claimed to show that people who took hydroxychloroquine to treat COVID-19 had a …

News
astrazeneca_building_white

AstraZeneca announces new partnerships to deliver two billion COVID-19 vaccine doses, with focus on developing countries

June 5, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, Vaccine, coronavirus

As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …

News
novartis_outside_1

Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study

June 4, 2020
Research and Development Cosentyx, Novartis, axial spondyloarthritis

New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …

News
rose_buddy

Trump’s Operation Warp Speed selects Pfizer, Merck, AstraZeneca and Moderna as vaccine finalists

June 4, 2020
Business Services COVID-19, Operation Warp Speed, Trump, coronavirus

The Trump administration has selected the finalists for the COVID-19 vaccine it is seeking to make widely available by the …

News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies

June 4, 2020
Research and Development Janssen, Tremfya, psoriatic arthritis

Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …

News
fitbitstand

Fitbit’s Flow ventilator receives FDA emergency approval

June 4, 2020
Business Services COVID-19, coronavirus, ventalitor

The FDA has granted emergency approval for Fitbit’s ‘Fitbit Flow’ ventilator, a low cost piece of equipment to help fight …

News
black_market

Hydroxychloroquine does not work as a preventative against COVID-19, new study finds

June 4, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

The malaria drug hydroxychloroquine does not protect people from COVID-19, according to a new study led by researchers at the …

News
remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …

News
chloroquine

Lancet expresses concern over published hydroxychloroquine and chloroquine paper

June 3, 2020
Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …

News
fda

The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening

June 3, 2020
Research and Development AAPS, COVID-19, coronaviryus

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …

News
ibuprofen

Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients

June 3, 2020
Research and Development COVID-19, coronavirus, ibuprofen

Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 3, 2020
Research and Development COVID-19, coronavirus

COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …

News
covid_cell

Eli Lilly launches clinical trial of COVID-19 antibody treatment

June 2, 2020
Manufacturing and Production COVID-19, coronavirus

Eli Lilly has announced they have started an early stage human trial to test an antibody treatment against coronavirus. The …

News

Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma

June 2, 2020
Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma

Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …

News
vote_leave

AI firm that worked with Vote Leave awarded contract to help Britain deal with COVID-19

June 2, 2020
Manufacturing and Production

The AI company Faculty, who worked on the Vote Leave campaign, have been awarded a £400,000 contract by the government …

News
zoloft

Antidepressant Zoloft falls into shortage due to anxiety around COVID-19

June 2, 2020
Manufacturing and Production COVID-19, coronavirus

The FDA has listed the antidepressant Zoloft to its catalogue of drugs that are in short supply in the United …

News
david_paul_morrisbloomberg

Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows

June 2, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026